U.S. market Open. Closes in 4 hours 41 minutes

LEXX | Lexaria Bioscience Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-07-312013-10-312012-10-312011-10-312010-10-312009-10-312008-10-312007-10-312006-10-312005-10-31
Revenue226.21K255.40K722.74K384.54K222.61K433.29K63.64K40.72K14.70KN/A1.10M1.36M1.13M362.47K421.95K900.79K253.15K20.31KN/A
Cost of Revenue31.50K71.84K175.35K99.38K22.89K25.18K29.75K45.62K29.88KN/A795.20K783.27K667.86K273.62K548.32K912.75K124.91K93.32KN/A
Gross Profit194.71K183.56K547.39K285.17K199.72K408.10K33.89K-4.90K-15.18KN/A302.25K574.49K465.91K88.86K-126.37K-11.96K128.24K-73.01KN/A
Operating Expenses6.73M7.57M6.23M4.27M4.26M7.01M1.90M1.21M1.91MN/A378.36K579.40K725.41K474.00K467.18K480.72K1.18M138.53K35.14K
Selling, General & Admin3.06M5.72M4.97M3.77M3.64M6.51M1.84M1.20M1.76MN/A372.31K565.35K719.01K467.23K458.97K479.45K1.03M141.51K35.14K
Research & Development3.67M1.84M1.26M387.07K555.73K492.86K54.19K9.02K146.47KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/A112.75K60.55K2.31K-886.004.60K3.58KN/A6.05K14.04K6.40K6.77K8.21K1.27K148.38K-2.99KN/A
Operating Income-6.53M-7.38M-5.69M-3.89M-3.96M-6.60M-1.86M-1.22M-1.93MN/A-76.11K-4.90K-259.50K-385.14K-593.55K-492.68K-1.05M-211.54K-35.14K
Other Expenses / Income-221.69K-764.61K1.52M-192.66K-197.23K-8.97K-68.21K-61.67K-55.06KN/A-267.44K-246.61K-278.73K-1.00N/A-478.67K-4.71K-278.12K-40.44K
Before Tax Income-6.71M-7.38M-4.16M-4.08M-4.16M-6.61M-1.93M-1.28M-1.98MN/A-343.55K-251.51K-538.23KN/AN/A-971.35K-1.05MN/AN/A
Income Tax Expenses130.88K-114.33K-1.66M-54.29K39.62K-8.97KN/AN/AN/AN/AN/AN/AN/AN/AN/A7.14K1.04KN/AN/A
Net Income-6.66M-7.27M-2.50M-4.03M-4.20M-6.60M-1.87M-1.21M-1.77MN/A-343.55K-251.51K-538.23K-552.46K-753.57K-978.49K-1.06M-508.26K-75.72K
Interest ExpensesN/AN/AN/AN/AN/AN/A6.01K2.25K31.54KN/A267.36K246.61K278.73K167.32K160.12KN/AN/AN/AN/A
Basic Shares Outstanding6.61M5.89M4.39M2.77M2.59M2.37M1.96M1.46M1.32M23.37M602.48K602.48K519.80K451.94K268.67K219.28K202.59K160.87K55.15K
Diluted Shares Outstanding6.61M5.89M4.39M2.77M2.59M2.37M1.96M1.46M1.32M23.37M602.48K602.48K519.80K451.94K268.67K219.28K202.59K160.87K55.15K
EBITDA-6.17M-7.24M-7.06M-3.78M-3.90M-6.60M-1.86M-1.21M-1.74MN/A-76.19K-4.90K-259.08K-384.12K-592.20K-518.23K-906.47K-426.50K5.30K
EBITDA Margin-2,726.22%-2,835.72%-977.11%-982.78%-1,752.23%-1,522.76%-2,925.52%-2,976.33%-11,828.02%0.00%-6.94%-0.36%-22.85%-105.97%-140.35%-57.53%-358.08%-2,100.25%0.00%
EBIT-6.53M-7.38M-4.16M-4.08M-4.16M-6.61M-1.86M-1.21M-1.74MN/A-76.19K-4.90K-259.50K-385.14K-593.45K-971.35K-1.05M-508.26K-75.72K
EBIT Margin-2,888.50%-2,891.05%-576.16%-1,062.20%-1,868.03%-1,525.04%-2,927.86%-2,977.86%-11,828.02%0.00%-6.94%-0.36%-22.89%-106.25%-140.64%-107.83%-416.69%-2,502.87%0.00%
Financial Year End2023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-07-312013-10-312012-10-312011-10-312010-10-312009-10-312008-10-312007-10-312006-10-312005-10-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙